Key Takeaways
- • Lakewood Capital Management, a $5 billion hedge fund led by Anthony Bozza, has taken short positions in Canopy Growth and Aurora Cannabis, expressing conviction that cannabis stock valuations will collapse.
- • Bozza argues that Canopy Growth's production capacity can be replicated for under CA$150 million despite a market cap of CA$6.6 billion, while Aurora's capacity costs approximately CA$100 million against a CA$6.2 billion valuation—indicating significant overvaluation risk.
- • The hedge fund identifies low barriers to entry and rapidly expanding licensed producer capacity in Canada as structural headwinds that will compress valuations, regardless of long-term industry growth prospects.
- • Current cannabis stock enthusiasm is driven by regulatory momentum, media coverage, and public acceptance, but these companies cannot legally sell into the U.S. market—a critical constraint on addressable market size versus investor expectations.
- • Aurora Cannabis management dismissed the short position, noting that previous shorts have been forced to cover repeatedly, signaling confidence in near-term price support despite fundamental concerns.
Summary
Lakewood Capital Management disclosed significant short positions in two leading Canadian cannabis producers, Canopy Growth and Aurora Cannabis, in its fourth-quarter 2017 investor letter obtained by CNBC. The $5 billion asset manager, led by Anthony Bozza, has positioned itself against one of 2018's most volatile and retail-driven investment themes, citing structural valuation disconnects and unfavorable competitive dynamics.
Bozza's thesis rests on a critical observation: the cannabis industry's low barriers to entry and rapid expansion of licensed producers in Canada will inevitably compress margins and valuations. He estimates that Canopy Growth's entire production capacity could be replicated for less than CA$150 million—a fraction of its CA$6.6 billion market capitalization. Similarly, Aurora's production infrastructure could be recreated for approximately CA$100 million against its CA$6.2 billion market value. These cost-to-market-cap ratios suggest substantial overvaluation in Bozza's assessment.
The hedge fund manager highlighted a secondary but significant constraint: none of these Canadian operators can legally sell into the U.S. market, despite the explosive growth narrative surrounding California's legalization. This regulatory limitation restricts addressable market opportunity relative to investor expectations shaped by headlines about North American cannabis legalization momentum. Bozza notes that much of the recent retail enthusiasm stems from regulatory tailwinds, media saturation, and growing public acceptance—factors that have attracted retail investors but obscure fundamental business limitations.
Aurora Cannabis management responded dismissively to the short position, with Chief Corporate Officer Cam Battley stating the company does not worry about short sellers, noting that previous shorts have been repeatedly forced to cover. The remark suggests confidence in near-term price momentum despite acknowledgment of the fundamental thesis underpinning the bearish position. Lakewood's net return for 2017 was 8 percent, reflecting a more cautious stance than many competitors during the cannabis rally.
Bozza's thesis rests on a critical observation: the cannabis industry's low barriers to entry and rapid expansion of licensed producers in Canada will inevitably compress margins and valuations. He estimates that Canopy Growth's entire production capacity could be replicated for less than CA$150 million—a fraction of its CA$6.6 billion market capitalization. Similarly, Aurora's production infrastructure could be recreated for approximately CA$100 million against its CA$6.2 billion market value. These cost-to-market-cap ratios suggest substantial overvaluation in Bozza's assessment.
The hedge fund manager highlighted a secondary but significant constraint: none of these Canadian operators can legally sell into the U.S. market, despite the explosive growth narrative surrounding California's legalization. This regulatory limitation restricts addressable market opportunity relative to investor expectations shaped by headlines about North American cannabis legalization momentum. Bozza notes that much of the recent retail enthusiasm stems from regulatory tailwinds, media saturation, and growing public acceptance—factors that have attracted retail investors but obscure fundamental business limitations.
Aurora Cannabis management responded dismissively to the short position, with Chief Corporate Officer Cam Battley stating the company does not worry about short sellers, noting that previous shorts have been repeatedly forced to cover. The remark suggests confidence in near-term price momentum despite acknowledgment of the fundamental thesis underpinning the bearish position. Lakewood's net return for 2017 was 8 percent, reflecting a more cautious stance than many competitors during the cannabis rally.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.